Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Hematopoietic stem cell autografts in support of myeloablative therapy for multiple myeloma.

Barlogie B, Jagannath S, Vesole D, Tricot G.

J Hematother. 1994 Summer;3(2):149-53.

PMID:
7922016
[PubMed - indexed for MEDLINE]
2.

High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma.

Long GD, Chao NJ, Hu WW, Negrin RS, Wong RM, Blume KG.

Cancer. 1996 Dec 15;78(12):2502-9.

PMID:
8952558
[PubMed - indexed for MEDLINE]
3.

High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma.

Awedan AA.

Ann Transplant. 2002;7(2):38-43. Review.

PMID:
12416471
[PubMed - indexed for MEDLINE]
Free Article
4.

Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma.

Lokhorst HM, Sonneveld P, Cornelissen JJ, Joosten P, van Marwijk Kooy M, Meinema J, Nieuwenhuis HK, van Oers MH, Richel DJ, Segeren CN, Veth G, Verdonck LF, Wijermans PW.

Bone Marrow Transplant. 1999 Feb;23(4):317-22.

PMID:
10100574
[PubMed - indexed for MEDLINE]
Free Article
5.

The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.

Kyle RA.

Ann Oncol. 2000;11 Suppl 1:55-8. Review.

PMID:
10707780
[PubMed - indexed for MEDLINE]
6.

High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.

Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J, Sharma A, Singh R, Kochupillai V.

Natl Med J India. 2003 Jan-Feb;16(1):16-21.

PMID:
12715951
[PubMed - indexed for MEDLINE]
7.

Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.

Kim JS, Kim K, Cheong JW, Min YH, Suh C, Kim H, Jo DY, Ryoo HM, Yoon SS, Lee JH; Korean Multiple Myeloma Working Party.

Biol Blood Marrow Transplant. 2009 Apr;15(4):463-70. doi: 10.1016/j.bbmt.2008.12.512.

PMID:
19285634
[PubMed - indexed for MEDLINE]
8.

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study.

Segeren CM, Sonneveld P, van der Holt B, Vellenga E, Croockewit AJ, Verhoef GE, Cornelissen JJ, Schaafsma MR, van Oers MH, Wijermans PW, Fibbe WE, Wittebol S, Schouten HC, van Marwijk Kooy M, Biesma DH, Baars JW, Slater R, Steijaert MM, Buijt I, Lokhorst HM; Dutch-Belgian Hemato-Oncology Cooperative Study Group.

Blood. 2003 Mar 15;101(6):2144-51. Epub 2002 Nov 27.

PMID:
12456509
[PubMed - indexed for MEDLINE]
Free Article
9.

Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study.

Tribalto M, Amadori S, Cudillo L, Caravita T, Del Poeta G, Meloni G, Avvisati G, Petrucci MT, Pulsoni A, Leone G, Sica S, Martelli M, Tabilio A, Fioritoni G, Majolino I, Mandelli F.

Haematologica. 2000 Jan;85(1):52-8.

PMID:
10629592
[PubMed - indexed for MEDLINE]
Free Article
10.

Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy.

Lemoli RM, Martinelli G, Zamagni E, Motta MR, Rizzi S, Terragna C, Rondelli R, Ronconi S, Curti A, Bonifazi F, Tura S, Cavo M.

Blood. 2000 Apr 1;95(7):2234-9.

PMID:
10733490
[PubMed - indexed for MEDLINE]
Free Article
11.

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial.

Moreau P, Facon T, Attal M, Hulin C, Michallet M, Maloisel F, Sotto JJ, Guilhot F, Marit G, Doyen C, Jaubert J, Fuzibet JG, François S, Benboubker L, Monconduit M, Voillat L, Macro M, Berthou C, Dorvaux V, Pignon B, Rio B, Matthes T, Casassus P, Caillot D, Najman N, Grosbois B, Bataille R, Harousseau JL; Intergroupe Francophone du Myélome.

Blood. 2002 Feb 1;99(3):731-5.

PMID:
11806971
[PubMed - indexed for MEDLINE]
Free Article
12.

Early myeloablative therapy for multiple myeloma.

Alexanian R, Dimopoulos MA, Hester J, Delasalle K, Champlin R.

Blood. 1994 Dec 15;84(12):4278-82.

PMID:
7994043
[PubMed - indexed for MEDLINE]
Free Article
13.

Total therapy with tandem transplants for newly diagnosed multiple myeloma.

Barlogie B, Jagannath S, Desikan KR, Mattox S, Vesole D, Siegel D, Tricot G, Munshi N, Fassas A, Singhal S, Mehta J, Anaissie E, Dhodapkar D, Naucke S, Cromer J, Sawyer J, Epstein J, Spoon D, Ayers D, Cheson B, Crowley J.

Blood. 1999 Jan 1;93(1):55-65.

PMID:
9864146
[PubMed - indexed for MEDLINE]
Free Article
14.

The effects of prior induction therapy with melphalan on subsequent peripheral blood progenitor cell transplantation for myeloma.

Kazmi MA, Ahsan G, Schey SA.

Clin Lab Haematol. 2001 Apr;23(2):125-9.

PMID:
11488852
[PubMed - indexed for MEDLINE]
15.

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.

Alegre A, Díaz-Mediavilla J, San-Miguel J, Martínez R, García Laraña J, Sureda A, Lahuerta JJ, Morales D, Bladé J, Caballero D, De la Rubia J, Escudero A, Díez-Martín JL, Hernández-Navarro F, Rifón J, Odriozola J, Brunet S, De la Serna J, Besalduch J, Vidal MJ, Solano C, Leon A, Sánchez JJ, Martínez-Chamorro C, Fernández-Rañada JM.

Bone Marrow Transplant. 1998 Jan;21(2):133-40.

PMID:
9489629
[PubMed - indexed for MEDLINE]
Free Article
16.
17.

High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Engenhart R, Wannenmacher M, Haas R.

Ann Oncol. 1997 Mar;8(3):243-6.

PMID:
9137792
[PubMed - indexed for MEDLINE]
Free Article
18.

High-dose therapy followed by autologous haematopoietic stem cell transplantation in multiple myeloma.

Koh LP, Linn YC, Teoh G, Goh YT, Tan PH.

Ann Acad Med Singapore. 2002 Nov;31(6):731-7.

PMID:
12520826
[PubMed - indexed for MEDLINE]
19.

[Value of hematopoietic stem cell autotransplantation in the treatment of multiple myeloma: initial experience at the National Bone Marrow Transplantation Center and review of the literature].

Abdelkefi A, Ladeb S, Ben Othman T, Torjman L, Jeddi R, Ben Abdeladhim A.

Tunis Med. 2000 Oct;78(10):548-56. French.

PMID:
11190737
[PubMed - indexed for MEDLINE]
20.

Hemopoietic stem cell transplants for multiple myeloma.

Jagannath S, Vesole DH, Tricot G, Crowley J, Salmon SE, Barlogie B.

Oncology (Williston Park). 1994 Nov;8(11):89-103; discussion 103-6. Review.

PMID:
7826841
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk